New York (ABC Live): Sofosbuvir :WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories Ltd., India. “This is a …
The post WHO Prequalifies First Generic Version of Sofosbuvir appeared first on ABC Live.